Two Cases of Lung Stage ⅢSquamous Cell Carcinoma Treated with Carboplatin (CBDCA)plus Nab-Paclitaxel(Nab-PTX)
Journal: Gan To Kagaku Ryoho. Cancer & Chemotherapy
Published:
Abstract
Case 1: 83 years old man. For left upper lobe lungs squamous cell carcinoma infiltrating left main pulmonary artery. After 2 courses went of carboplatin(CBDCA)(AUC: 6)+weekly nab-paclitaxel(nab-PTX)(AUC: 6)+, left upper lobectomy and ND2 lymph nodes dissection. Tumor disappeared in pathology and diagnosed of Ef. 3. Case 2: 81 years old man. Right upper lobe lungs squamous cell carcinoma in #4R lymph node metastasis with the superior vena cava invasion. After 2 courses went of CBDCA(AUC: 6)+weekly nab-PTX(100mg/m2), left upper lobectomy and ND2 lymph nodes dissection. Tumor disappeared in pathology and diagnosed of Ef. 3. Nab-PTX may be considered a preoperative chemotherapeutic agent of choice for squamous cell carcinoma.
Authors
Yutaro Yoshino, Jun Miyagi, Reo Toume, Yui Naha, Teruhito Uchihara, Morikazu Akamine, Hidetsugu Nakazato, Masayo Kawakami, Takehiko Tomori, Seiji Nagayoshi, Shinji Nagamine, Takeshi Tomiyama, Yasushi Ohmine, Hideaki Sasaki, Masashi Ishikawa, Kanetaka Maeshiro
Relevant Conditions